. 2012 Mar 26;17(4):3723–3735. doi: 10.3390/molecules17043723

Table 1.

Effects of DELA on S180 in Mice (Mean ± S.D.) (n = 10).

Group	Dose (mg/kg)	Weight (g)		Tumor weight (g)	Inhibitory rate (%)	Thymus index (mg/g)	Spleen index (mg/g)
Group	Dose (mg/kg)	Before treatment	After treatment	Tumor weight (g)	Inhibitory rate (%)	Thymus index (mg/g)	Spleen index (mg/g)
model control	-	19.49 ± 1.21	28.36 ± 3.05	1.29 ± 0.38		2.19 ± 0.80	7.43 ± 1.29
CTX	20	19.33 ± 1.38	22.57 ± 1.47	0.41 ± 0.12 **	68.22	1.03 ± 0.16	5.28 ± 1.04
DELA	120	19.18 ± 1.57	27.94 ± 2.25	0.60 ± 0.14 **	53.49	2.98 ± 0.61 *^a	9.95 ± 1.87 *^a
DELA	40	19.44 ± 1.82	28.35 ± 2.61	0.81 ± 0.19	37.21	2.46 ± 0.53 ^a	9.22 ± 1.59 ^a
DELA	20	19.61 ± 1.16	29.17 ± 2.79	0.93 ± 0.22	27.9	2.23 ± 0.59 ^a	8.98 ± 1.40 ^a

CTX is the abbreviation of cyclophosphamide. ^a Significantly different from CTX group at p < 0.01; * significantly different from model control group at p < 0.05; ** significantly different from model control group at p < 0.01.